Tyra Biosciences

Tyra Biosciences is a clinical-stage biopharmaceutical company (NASDAQ: TYRA) based in Carlsbad, California, focused on developing next-generation precision medicines that address the emergence of tumor resistance and other challenges in existing treatment options. Tyra's proprietary in-house SNAP discovery platform combines advanced protein crystallography with structure-based drug design, producing full structural "SNAPshots" of the real-world interaction between a drug and its target in as little as seven days rather than weeks to months. This rapid, sequential structural iteration lets the team refine molecular designs to angstrom-level precision and design selective inhibitors intended to deliver deeper, more durable responses for patients, including in cancers where resistance mutations block first-generation drugs. Tyra was surfaced as a portfolio company of Canaan Partners. It is a therapeutics company and does not publish a public developer API, SDK, or API documentation surface.

Tyra Biosciences is profiled on the APIs.io network. Tagged areas include Company, Biotechnology, Pharmaceuticals, Precision Medicine, and Drug Discovery.

Tyra Biosciences’ developer surface includes support and 6 more developer resources.

🌐 Visit website 📡 Source on GitHub
14.6/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-07-27 · rubric v0.5
0 APIs
CompanyBiotechnologyPharmaceuticalsPrecision MedicineDrug DiscoveryOncologyTherapeuticsLife Sciences

Kin Score

Kin Score Kin Score How this is scored →
scored 2026-07-27 · rubric v0.5
Composite quality — 14.6/100 · minimal
Contract Quality 0.0 / 25
Developer Ergonomics 0.9 / 20
Commercial Clarity 4.2 / 20
Operational Transparency 0.0 / 13
Governance 0.0 / 12
Discoverability 6.8 / 10
Agent readiness — 0/100 · human only
Machine-Readable Contract 0 / 18
Agentic Access Contract 0 / 15
MCP Server 0 / 12
Machine-Readable Auth 0 / 10
Idempotency 0 / 9
Stable Error Semantics 0 / 8
Request/Response Examples 0 / 7
Rate-Limit Signaling 0 / 7
Typed Event Surface 0 / 6
Agent Skills 0 / 5
Well-Known Catalog 0 / 4
Consent & Bot Identity 0 / 3
Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/tyra: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Security Posture 1

Authentication, domain security, vulnerability disclosure, and trust-center signals.

Tyra Domain Security

TLSv1.3 · DMARC

SECURITY

Resources

Access & Security 1

Authentication, authorization, and security posture

DomainSecurity
DomainSecurity

Operate 1

Status, limits, changes, and where to get help

Support
Support

Commercial 2

Pricing, plans, and the legal terms of use

PrivacyPolicy
PrivacyPolicy
 TermsOfService
TermsOfService

Company 3

The organization behind the API

Website
Website
 InvestorRelations
InvestorRelations
 LinkedIn
LinkedIn

Source (apis.yml)

apis.yml Raw ↑ 
aid: tyra
name: Tyra Biosciences
description: 'Tyra Biosciences is a clinical-stage biopharmaceutical company (NASDAQ: TYRA) based in Carlsbad, California,
  focused on developing next-generation precision medicines that address the emergence of tumor resistance and other challenges
  in existing treatment options. Tyra''s proprietary in-house SNAP discovery platform combines advanced protein crystallography
  with structure-based drug design, producing full structural "SNAPshots" of the real-world interaction between a drug and
  its target in as little as seven days rather than weeks to months. This rapid, sequential structural iteration lets the
  team refine molecular designs to angstrom-level precision and design selective inhibitors intended to deliver deeper, more
  durable responses for patients, including in cancers where resistance mutations block first-generation drugs. Tyra was surfaced
  as a portfolio company of Canaan Partners. It is a therapeutics company and does not publish a public developer API, SDK,
  or API documentation surface.'
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://tyra.bio/wp-content/uploads/2021/08/cropped-favicon-192x192.png
url: https://raw.githubusercontent.com/api-evangelist/tyra/refs/heads/main/apis.yml
humanURL: https://tyra.bio/
x-type: company
x-source: vc-portfolio
x-backed-by:
- canaan-partners
x-tier: stub
x-tier-reason: portfolio-lead
x-industry: biotechnology
specificationVersion: '0.20'
created: '2026-07-17'
modified: '2026-07-21'
tags:
- Company
- Biotechnology
- Pharmaceuticals
- Precision Medicine
- Drug Discovery
- Oncology
- Therapeutics
- Life Sciences
apis: []
common:
- type: DomainSecurity
  url: security/tyra-domain-security.yml
- type: Website
  url: https://tyra.bio/
- type: PrivacyPolicy
  url: https://tyra.bio/privacy-policy/
- type: TermsOfService
  url: https://tyra.bio/terms-conditions/
- type: Support
  url: https://tyra.bio/contact/
- type: InvestorRelations
  url: https://ir.tyra.bio/
- type: LinkedIn
  url: https://www.linkedin.com/company/tyra-biosciences/
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
x-enrichment:
  date: '2026-07-21'
  status: minimal
  artifacts_added: 1
  pass: local-v1